Refine by
Coronary Heart Disease Articles & Analysis
9 news found
Revacept proved to be particularly effective when stroke, bleeding and heart attack were considered together. Here, the novel active ingredient in the dosage of 120 milligrams caused a significant reduction of more than 54 percent compared to those treated with placebo. ...
AI is also bringing clinicians and specialties together to extend the value of radiology to address the #1 killer of women, heart disease. Featured at this year’s event, Kevin Harris, President and co-Founder of CureMetrix, will present new and national research on breast cancer detection and will show how leveraging AI to stratify the risk of ...
ISH is the predominant form of hypertension in patients over 60 years old and the most challenging to treat; elevated Pulse Pressure is a significant, independent risk factor of coronary heart disease. Orchestra BioMed, Inc., (“Orchestra BioMed” or the “Company”), a biomedical innovation company focused on developing ...
Harris will review innovative AI decision support tools, and share new, national research that shows how leveraging AI to stratify the risk of coronary heart disease (CHD) by detecting and quantifying Breast Arterial Calcifications (BAC) from screening mammograms will benefit imaging centers, healthcare systems, and millions of women in the U.S. ...
The novel drug Revacept can reduce heart attacks and strokes more efficient and safer than previous standard therapies. ...
Volta Medical, a pioneering French-based HealthTech startup, working on novel artificial intelligence (AI) algorithms to treat cardiac arrythmias, today announced that it has successfully raised 23 million Euros. The financing round was led by Gilde Healthcare with participation of existing shareholder Pasteur Mutualité. The new capital will allow the company to establish its revolutionary ...
Volta Medical, a pioneering French-based HealthTech startup is pleased to announce that it has obtained FDA clearance for its revolutionary VX1 AI (artificial intelligence) software. This is the first FDA clearance for an AI based tool in interventional cardiac electrophysiology. VX1 is a machine and deep learning-based algorithm designed to assist operators in the real-time manual annotation of ...
The expert report highlights health effects, with different levels of scientific evidence: effects such as sleepiness, reduced sleep quality and reduced total sleeping time, and metabolic syndrome are proven; the effects on mental health, cognitive performance, obesity and weight gain, type 2 diabetes and coronary heart disease ...
In the course of our group-wide charity project, Pipelife Finland has divided its donation in two parts in order to support two organizations: the Northern Ostrobothnia Heart Association and the Save the Children Foundation. The Northern Ostrobothnia regional heart association is a part of the Finnish Heart Association and promotes ...